High expression of ERCC1, FLT1, NME4 and PCNA associated with poor prognosis and advanced stages in myelodysplastic syndrome

References

• Cazzola M, Malcovati L. Myelodysplastic syndromes – coping with ineffective hematopoiesis. N Engl J Med 2005; 352: 536–538
   PubMed Web of Science ®Google Scholar
• Greenberg P, Cox C, LeBeau M M, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079–2088
   PubMed Web of Science ®Google Scholar
• Gallagher A, Darley R L, Padua R. The molecular basis of myelodysplastic syndromes. Haematologica 1997; 82: 191–204
   PubMed Web of Science ®Google Scholar
• Solé F, Espinet B, Sanz G F, Cervera J, Calasanz M J, Luño E, et al. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromesGrupo Cooperativo Español de Citogenética Hematológica. Br J Haematol 2000; 108: 346–356
   PubMed Web of Science ®Google Scholar
• Miyazato A, Ueno S, Ohmine K, Ueda M, Yoshida K, Yamashita Y, et al. Identification of myelodysplastic syndrome-specific genes by DNS microarray analysis with purified hematopoietic stem cell fraction. Blood 2001; 98: 422–427
   PubMed Web of Science ®Google Scholar
• Pellagatti A, Esoof N, Watkins F, Langford C F, Vetrie D, Campbell L J, et al. Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology. Br J Haematol 2004; 125: 576–583
   PubMed Web of Science ®Google Scholar
• Pellagatti A, Cazzola M, Giagounidis A AN, Malcovati L, Porta M GD, Killick S, et al. Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon stimulated genes an correlation to FAB subtype and karyotype. Blood 2006; 108: 337–345
   PubMed Web of Science ®Google Scholar
• Hofmann W K, de Vos S, Komor M, Hoelzer D, Wachsman W, Koeffler H P. Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Blood 2002; 100: 3553–3560
   PubMed Web of Science ®Google Scholar
• Chen G, Zeng W, Miyazato A, Billings E, Maciejewski J P, Kajigaya S, et al. Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities. Blood 2004; 140: 4210–4218
   Web of Science ®Google Scholar
• Nilsson L, Eden P, Olsson E, Mansson R, Astrand-Grundstrom I, Strombeck B, et al. The molecular signature of MDS stem cells supports a stem cell origin of 5q-myelodysplastic syndromes. Blood 2007; 110: 3005–3014
   PubMed Web of Science ®Google Scholar
• Ueda M, Ota J, Yamashita Y, Choi Y L, Ohki R, Wada T, et al. DNA microarray analysis of stage progression mechanism in myelodysplastic syndrome. Br J Haematol 2003; 123: 288–296
   PubMed Web of Science ®Google Scholar
• Chomczynsky P, Sacchi N. Single step Metod of RNA isolation by acid quanidin-isothiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Livak K J, Schmittgen T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402–408
   PubMed Web of Science ®Google Scholar
• Ito M, Tsurusawa M, Zha Z, Kawai S, Takasaki Y, Fujimoto T. Cell proliferation in childhood acute leukemia. Comparison of Ki-67 and proliferating cell nuclear antigen immunocytochemical and DNA flow cytometric analysis. Cancer 1992; 69: 2176–2182
   PubMed Web of Science ®Google Scholar
• Okabe-Kado J. Serum nm23-H1 protein as a prognostic factor in hematological malignancies. Leuk Lymphoma 2002; 43: 859–867
   PubMed Web of Science ®Google Scholar
• Hayer J, Engel M, Seifert M, Seitz G, Welter C. Overexpression of nm23-H4 RNA in colorectal and renal tumours. Anticancer Res 2001; 21: 2821–2825
   PubMed Web of Science ®Google Scholar
• Seifert M, Welter C, Mehraein Y, Seitz G. Expression of the nm23 homologues nm23-H4, nm23-H6, and nm23-H7 in human gastric and colon cancer. J Pathol 2005; 205: 623–632
   PubMed Web of Science ®Google Scholar
• Verstovsek S, Estey E, Manshouri T, Giles F J, Cortes J, Beran M, et al. Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndrome. Br J Haematol 2002; 118: 151–156
   PubMed Web of Science ®Google Scholar
• Hu Q, Dey A L, Yang Y, Shen Y, Jilani I B, Estey E H, et al. Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes. Cancer 2004; 100: 1884–1891
   PubMed Web of Science ®Google Scholar
• Wierzbowska A, Robak T, Wrzesień-Kuś A, Krawczyńska A, Lech-Marańda E, Urbańska-Ryś H. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia. Eur Cytokine Network 2003; 14: 149–153
   PubMed Web of Science ®Google Scholar
• Azuma K, Komohara Y, Sasada T, Terazaki Y, Ikeda J, Hoshino T, et al. Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy. Cancer Sci 2007; 98: 1336–1343
   PubMed Web of Science ®Google Scholar
• Olaussen K A, Dunant A, Fouret P, Brambilla E, André F, Haddad V, et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 2006; 355: 983–991
   PubMed Web of Science ®Google Scholar
• Bruchova H, Kalinova M, Brdicka R. Array-based analysis of gene expression in childhood acute lymphoblastic leukemia. Leuk Res 2004; 28: 1–7
   PubMed Web of Science ®Google Scholar
• Giglio A, Drach J, Kornblau S M, Patel S, Novaes M, Khetan R, et al. Quantitive expression of proliferating cell nuclear antigen by western blot (PCNAWB) in peripheral blasts correlates with remission induciton in patients with acute myelogenous leukemia. Leuk Lymphoma 1995; 19: 235–241
   PubMed Web of Science ®Google Scholar
• Orazi A, Albitar M, Heerema N A, Haskins S, Neiman R S. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens. Am J Clin Pathol 1997; 107: 268–274
   PubMed Web of Science ®Google Scholar
• Kitagawa M, Kamiyama R, Kasuga T. Expression of the proliferating cell nuclear antigen in bone marrow cells from patients with myelodysplastic syndromes and aplastic anemia. Hum Pathol 1993; 24: 359–363
   PubMed Web of Science ®Google Scholar
• Alexandrakis M G, Passam F H, Dambaki K, Passam A M, Nalbanti F, Stathopoulos E S, et al. The assessment of proliferating cell nuclear antigen immunostaining in myelodysplastic syndromes and its prognostic significance. Eur J Histochem 2005; 49: 27–32
   PubMed Web of Science ®Google Scholar